RHO and retinitis pigmentosa 1: Among future gene therapies for RP, there is a combination of gene therapy and so-called optogenetics, with two complementary components: a construct, encoding a photoactivatable channel rhodopsin protein, delivered via a modified adenovirus vector, and biomimetic goggles that stimulate the engineered retinal cells [50,51].